(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Scientists discover black hole flare with the light of 10 trillion suns - 2As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
- 3Outside Lovers' Decision: Favored Climbing Rucksacks
- 4Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
- 5Best Wellness Tracker Keep You On target
- Find Exemplary Scents: An Extensive Aide
- Passover under fire: Israelis balance fatigue with cautious hope after month of war
- Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- Former ‘Dancing with the Stars’ Pro Survives Plane Crash at LaGuardia That Left 2 Pilots Dead
- Why More Couples Are Choosing Africa For Their Honeymoon
- New dietary guidelines recommend more dairy, meat and fats: What to know
- 7 Countries Where You Can Buy a Home for Under $100,000
- Your kid wants it now. What saying yes, no or not yet teaches kids about money and instant gratification.
- Big Bear glows with big stars | Space photo of the day for Dec. 31, 2025
